News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Zai Lab (US) LLC
NEWS
JOBS
IN THE PRESS
NEWS
Business
Biopharma Companies Entering 2021 With New Collabs, Partnerships
Here’s a run-down of some of the most recent collaboration announcements this week.
January 8, 2021
·
4 min read
·
Brandon May
Business
BioSpace Movers & Shakers. Dec. 4
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
December 3, 2020
·
7 min read
·
Alex Keown
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer
May 19, 2025
·
5 min read
Press Releases
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates
May 8, 2025
·
19 min read
Press Releases
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
April 24, 2025
·
6 min read
Press Releases
Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors
April 21, 2025
·
5 min read
Press Releases
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025
April 14, 2025
·
1 min read
Press Releases
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
March 27, 2025
·
5 min read
Press Releases
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer
March 13, 2025
·
6 min read
Press Releases
Zai Lab Announces Participation in Investor Conferences in March 2025
March 3, 2025
·
1 min read
Press Releases
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates
February 27, 2025
·
19 min read
Press Releases
Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025
January 28, 2025
·
1 min read